Renal, volume, and hormonal changes during therapeutic administration of recombinant interleukin-2 in man
- 1 December 1987
- journal article
- research article
- Published by Elsevier in American Journal Of Medicine
- Vol. 83 (6), 1055-1061
- https://doi.org/10.1016/0002-9343(87)90941-7
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coliScience, 1984
- Renal Syndromes Associated with Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1984
- Increased Excretion of Urinary N-Acetyl-β-Glucosaminidase in Essential Hypertension and Its Decline with Antihypertensive TherapyNew England Journal of Medicine, 1983
- Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.JCI Insight, 1983
- Structure and expression of a cloned cDNA for human interleukin-2Nature, 1983
- Urinary enzymes, nephrotoxicity and renal diseaseToxicology, 1982
- The Effect of Indomethacin on Kidney Function and Plasma Renin Activity in ManNephron, 1976